期刊文献+

PKC对大肠癌耐药LoVo/Adr细胞阿霉素摄入及分布的影响

The effects of protein kinase C on the uptake and distribution of adriamycin in the multidrug resistant LoVo/Adr cells of colorectal carcinoma
暂未订购
导出
摘要 目的 观察PKC对耐药LoVo/Adr细胞阿霉素摄入及分布的影响 ,探讨其与耐药的关系。方法 采用流式细胞术检测阿霉素在细胞中的摄入 ;利用荧光显微镜观察阿霉素在细胞内的分布 ;采用免疫组化法检测P gp的表达。结果 P gp染色 :Lo Vo细胞株均为阴性 ,而耐药株LoVo/Adr细胞膜呈强阳性 ;LoVo/Adr细胞内阿霉素含量显著低于LoVo细胞 ,加入PMA后 ,Lo Vo/Adr细胞内ADR含量进一步减少 ;加入SP后 ,LoVo/Adr细胞内ADR含量明显升高。在敏感LoVo细胞中 ,阿霉素集中分布在核区 ,胞浆中很少 ;而在LoVo/Adr细胞中 ,阿霉素核区分布明显减少 ,相对在胞浆中增多 ,加入PMA或SP ,均不能改变阿霉素在细胞中的分布。结论 阿霉素在耐药细胞中不仅摄入减少 ,而且分布异常 ,PKC可能是通过影响耐药细胞对阿霉素的摄入而不是药物分布来调节MDR。 Objective To observe the effects of protein kinase C on the uptake and distribution of ADR in the multidrug resistant LoVo/Adr cells of colo rectal carcinoma. Methods The uptake of ADR in cells was studied by flow cytometry and the distribution of ADR in cells was examined by fluorescent microscope. The expression of P gp was detected by immunohistochenical method. Results P gp stain was negative in LoVo cells, but intensively positive in LoVo/ADR cells. The concentration of ADR was in LoVo/Adr cells was significantly lower than that in LoVo cells. The uptake of ADR was reduced after treating with PMA in LoVo/Adr cells, but was significantly increased after treating with SP. The fluorescence of ADR in the drug sensitive LoVo cells was mainly distributed in the nucleus, but only a little in the cytoplasm. While the distribution of ADR in LoVo/Adr cells markedly decreased in the nucleus and relatively increased in the cytoplasm. Neither PMA nor SP could change the distribution of ADR in LoVo/Adr cells. Conclusion Not only the uptake of ADR decreased but also the distribution of ADR was abnormal in resistant cells. PKC might modify multidrug drug resistance by effecting on the uptake but not on the distribution of ADR in resistance cells.
出处 《肿瘤》 CAS CSCD 北大核心 2002年第4期303-304,321,F003,共4页 Tumor
关键词 蛋白激酶C 多药耐药 药物分布 药物摄入 免疫组织化学 阿霉素 大肠癌 Protein kinase C Multidrug resistance Drug uptake Drug distribution
  • 相关文献

参考文献9

  • 1[1]Chaudhary PM, Robinson IB. Induction of MDRl(P-glycoprotein) gene expression in human cells by protein kinase C agonists. Oncol Res, 1992,4(3):281
  • 2[2]Beck JF, Brugger D, Brischwein K, et al. Anticancer drug-mediated induction of multidrng resistance-associated genes and protein kinase C isozymes in the t-lymphoblestoid cell line ccrf-cem and in blasts from patients with acute lymphoblastic leukemias.Jpn J Cancer Res, 2001,92(8) :896
  • 3[3]Merritt J E, Sullivan J A, Drew L, et al. The bisindolylmaleimide protein kinase C inhibitor, Ro 32-2241, reverses multidrug resistance in KB tumnout cells. Cancer Chemother Pharrnacol, 1999, 43(5):371
  • 4[4]Leveque D, Jehl F. P-glycoprotein and pharmacokinetics. Anticancer Res, 1995,15(2) :331
  • 5[5]Ward NE, O' Brian CA. Distinct patterns of phorbol ester-induced downregulation of protein kinase C activity in adriamycinselected multidrug resistant and parental murine fibmsarcoma cells. Cancer Lett, 1991 ;58(3): 189
  • 6[6]Gollapudi S, Patel K, Jain V, et al. Protein kinase C isoforms in multidrug resistant P388/ADR cells: a possible role in daunorubicin transport. Cancer Lett, 1992;62(1):69
  • 7[7]Cheng AL, Chuang SE, Fine RL, et al. Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen. Biochem Pharmacol, 1998, 55(4):523
  • 8[8]Morjani H, Millot JM, Belhoussine R, et al. Anthracycline subcellular distribution in human leukemic cells by microspectrofluorometry: factors contributing to drug-induced cell death and reversal of multidrug resistance. Leukemia, 1997, 11 (7):1170
  • 9[9]Weaver JL, Pine PS, Aszalos A, et al. Laser scanning and confocal microscopy of daunorubicin, doxombicin, and rhodamine 123 in multidrug-resistant cells. Exp Cell Res, 1991,196 (2):323

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部